4.5 Article

Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases

期刊

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-18-0523

关键词

-

向作者/读者索取更多资源

Background: Colorectal cancer is the third most commonly diagnosed cancer in Australia. Emerging evidence from several countries suggests increasing incidence in people aged <50 years. Methods: We assessed colon and rectal cancer incidence trends in people aged 20+ in Australia from 1982 to 2014. We used data on 375,008 incident cases (248,162 colon and 126,846 rectal). We quantified the annual percentage change (APC) in rates by age group using Joinpoint regression. Results: For people aged <50 years, colon cancer rates increased from the mid-2000s, with the increase in APCs ranging from 1.7% to 9.3% per annum (depending on specific age group); rectal cancer rates increased from the early 1990s, with APCs ranging from 0.9% to 7.1% per annum. For people aged 50 to 69 years, colon and rectal cancer rates decreased from the mid-1990s, with the decrease in APCs in specific age groups ranging from 0.8% to 4.8% per annum (except for colon cancer in those ages 65 to 69 years, where similar rate decreases were observed from 2007). An overall reduction in older persons (>70 years) was estimated at 1.9% to 4.9% per annum for colon cancer from 2010 onward and 1.1% to 1.8% per annum in rectal cancer from the early 2000s onward. Conclusions: Colon and rectal cancer incidence has increased in people aged <50 years in Australia over the last two decades. However, colon and rectal cancer rates decreased in people aged 50+, likely due to de facto and organized bowel cancer screening. Impact: Further research is needed to examine the cause of the increase and to quantify the impact of future trends on the cost-effectiveness of population-based screening for those <50 years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Public, Environmental & Occupational Health

The 'hot zone policy' for colorectal cancer screening presents unique risks and opportunities for rural Australia

Joachim Worthington, Jie-Bin Lew, Emily He, Kate Broun, Katina D'Onise, Paul Grogan, Karen Canfell, Eleonora Feletto

Summary: Colorectal cancer has geographic inequities in Australia, with higher mortality rates and lower participation in the National Bowel Cancer Screening Program (NBCSP) in remote and rural areas. This study describes the demographics of HZP areas and estimates the impacts of potential screening changes.

AUSTRALIAN JOURNAL OF RURAL HEALTH (2023)

Article Oncology

Female reproductive and hormonal factors and lung cancer mortality among never-smokers: A prospective cohort study of 287 408 Chinese women

Elvin S. Cheng, Louiza S. Velentzis, Marianne Weber, Julia Steinberg, Karen Canfell, Xue Qin Yu

Summary: There is emerging evidence suggesting that oestrogen may be involved in lung cancer development, especially among never-smoking women. A large-scale study in China found that factors such as age at menarche, age at menopause, time since menopause, prior use of oral contraceptives, number of livebirths, breastfeeding, and age at first livebirth were associated with increased risk of lung cancer death among never-smoking women. These findings highlight the potential role of reproductive factors in lung cancer development.

INTERNATIONAL JOURNAL OF CANCER (2023)

Editorial Material Medicine, General & Internal

Reflections on the life and career of Professor Dame Valerie Beral AC DBE FRS FRCOG FMedSci (1943-2022)

Karen Canfell, Bette Liu, Emily Banks

MEDICAL JOURNAL OF AUSTRALIA (2023)

Article Multidisciplinary Sciences

Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study

David M. Goldsbury, Amy Vassallo, Marianne Weber, Julia Steinberg, Penelope Webb, Anna DeFazio, Karen Canfell

Summary: This study aimed to estimate the direct health system costs of women diagnosed with ovarian cancer in Australia during 2006-2013, and found that the costs are substantial. Continued investment in ovarian cancer research, including prevention, early detection, and personalized treatments, is necessary to reduce the burden of the disease.

PLOS ONE (2023)

Article Substance Abuse

Fifty-year forecasts of daily smoking prevalence: can Australia reach 5% by 2030?

Stephen Wade, Marianne F. Weber, Peter Sarich, Michael Caruana, Christina Watts, Pavla Vaneckova, Preston Ngo, Sonya Cressman, Michelle Scollo, Emily Banks, Coral E. Gartner, Paul B. Grogan, Tony Blakely, Martin C. Tammemagi, Karen Canfell

Summary: This study aimed to compare 50-year forecasts of Australian tobacco smoking rates in relation to smoking initiation and cessation trends and a national target of <= 5% adult daily prevalence by 2030. Using a compartmental model and population predictions, the study estimated smoking prevalence to 2066 and compared scenarios of different trends in initiation and cessation rates. The results showed that current trends will not achieve the target by 2030, and urgent strategies are needed to prevent initiation and facilitate cessation.

TOBACCO CONTROL (2023)

Article Multidisciplinary Sciences

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

Sophie O'Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox, Maarten IJzerman

Summary: NTRK gene fusions are rare somatic mutations found in various cancer types, and targeted therapies for them are emerging. However, integrating these treatments into healthcare systems poses challenges due to uncertain prevalence and optimal testing methods. To address this, a systematic review was conducted to determine the prevalence of NTRK fusions and guide efficient diagnostic screening. The review included 160 studies and found that NTRK fusion-positive cancers are rare and widely distributed across solid tumors. However, small-scale and heterogeneous data make it difficult to predict prevalence accurately. Further large-scale, standardized genomic data are needed to better understand NTRK fusion epidemiology.

SCIENTIFIC REPORTS (2023)

Article Medicine, General & Internal

Engaging lower screening groups: a field experiment to evaluate the impact of a multiwave national campaign on participation in the National Bowel Cancer Screening Program

Claudia Gascoyne, Kate Broun, Belinda Morley, Kerryann Wyatt, Eleonora Feletto, Sarah J. Durkin

Summary: This study evaluated the impact of a multiwave media campaign on the participation rate of the Australian National Bowel Cancer Screening Program. The campaign significantly increased the rate of iFOBT kits returned, especially among younger individuals and those who had never participated in screening.

BMJ OPEN (2023)

Article Biology

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia

Carolyn Nickson, Megan A. Smith, Eleonora Feletto, Louiza S. Velentzis, Kate Broun, Sabine Deij, Paul Grogan, Michaela Hall, Emily He, D. James St John, Jie-Bin Lew, Pietro Procopio, Kate T. Simms, Joachim Worthington, G. Bruce Mann, Karen Canfell, Talia Malagon

Summary: Australia introduced COVID-19 infection prevention and control measures and conducted a modelled evaluation of the impact of disruptions to cancer screening programmes. The findings showed that a 12-month screening disruption would reduce breast and colorectal cancer diagnoses, but increase cervical cancer diagnoses. Maintaining screening participation is critical to preventing an increase in the burden of cancer at a population level.
Article Public, Environmental & Occupational Health

Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study

Susan Yuill, Sam Egger, Megan A. Smith, Louiza Velentzis, Marion Saville, Erich Kliewer, Deborah Bateson, Karen Canfell

Summary: This study compared the participation in the National Cervical Screening Program (NCSP) between immigrants and Australian-born women. The results showed that women from New Zealand, Oceania, Middle East/North Africa, Southeast Asia, Chinese Asia, Japan/South Korea, and Southern/Central Asia had lower screening participation rates, while women from Malta and South America had higher participation rates. Non-English-speaking-at-home women were less likely to be screened. Even after living in Australia for over 20 years, immigrant groups still had lower screening rates compared to Australian-born women. This study suggests that there is room for improvement in screening participation for these groups.

JOURNAL OF MEDICAL SCREENING (2023)

Article Economics

Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia

Preston Ngo, Deme Karikios, David Goldsbury, Stephen Wade, Zarnie Lwin, Brett G. M. Hughes, Kwun M. Fong, Karen Canfell, Marianne Weber

Summary: New therapies have improved the standard of care for lung cancer since 2016, leading to a need for up-to-date evidence in health economic modelling. A discrete event simulation of advanced lung cancer treatment was developed to estimate survival outcomes and healthcare costs in the Australian setting, which can be updated as new therapies are introduced.

PHARMACOECONOMICS (2023)

Article Virology

Natural History of Oral HPV Infection among Indigenous South Australians

Xiangqun Ju, Sneha Sethi, Annika Antonsson, Joanne Hedges, Karen Canfell, Megan Smith, Gail Garvey, Richard M. Logan, Lisa M. Jamieson

Summary: This study investigated the natural history and risk factors of oral HPV infections in an Australian Indigenous cohort. Data was collected from Indigenous Australians aged 18+ years through face-to-face interviews and saliva samples. The prevalence, incidence, and persistence of oral HPV infection were high in this population, with oral sex behaviors and recreational drug use identified as risk factors for high-risk HPV infection.

VIRUSES-BASEL (2023)

Meeting Abstract Respiratory System

Economics, equity and eligibility: Using risk models versus age-smoke history categorical criteria for selection to the international lung screening trial

Sonya Cressman, Marianne Weber, Preston Ngo, Alain Tremblay, Stephen Wade, Renee Manser, Emily Stone, Sukhinder Atkar-Khattra, Deme Karikios, Cheryl Ho, Silvia Behar Harpaz, Michael Caruana, Aleisha Fernandes, Jing Yi Weng, Annette McWilliams, Renelle Meyers, John Mayo, John Yee, Ren Yuan, Henry Marshall, Kwun Fong, Stephen Lam, Karen Canfell, Martin Tammemagi

RESPIROLOGY (2023)

Meeting Abstract Respiratory System

Personalised risk categorisation of participants at screening entry in the international lung screen trial

Annette McWilliams, Jacqueline Logan, Fraser Brims, Henry Marshall, Linda Passmore, Barbara Page, Emily Stone, Renee Manser, Paul Fogarty, Sriyani Parsons, Sukhinder Atkar-Khattra, Sonya Cressman, Renelle Myers, Martin Tammemagi, Marianne Weber, Karen Canfell, Kwun Fong, Stephen Lam

RESPIROLOGY (2023)

Meeting Abstract Respiratory System

Modelled costs and survival estimates for individuals with stage IV lung cancer

Preston Ngo, Deme Karikios, David Goldsbury, Stephen Wade, Brett Hughes, Zarnie Lwin, Karen Canfell, Nick Pavlakis, Marianne Weber

RESPIROLOGY (2023)

Meeting Abstract Respiratory System

A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The LEAPp program

Pavla Vaneckova, Stephen Wade, Michael Caruana, Preston Ngo, Silvia Behar Harpaz, Peter Sarich, Qingwei Luo, David Goldsbury, Elvin Cheng, Xue Qin Yu, Katherine Barron, Mei Ling Yap, Paul Grogan, Emily Banks, Kwung Fong, Henry Marshall, Deme Karikios, Nicole Rankin, Sonya Cressman, Martin Tammemagi, Annette McWilliams, Marianne Weber, Karen Canfell

RESPIROLOGY (2023)

暂无数据